User profiles for Stephen Archer

Stephen L. Archer

- Verified email at queensu.ca - Cited by 53436

Stephen D. Archer

- Verified email at bigelow.org - Cited by 4633

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus …

…, VV McLaughlin, SL Archer… - Circulation, 2009 - Am Heart Assoc
Pulmonary hypertension (PH) is a complex, multidisciplinary disorder. Recent advances
have led to increased recognition and new therapies. While some data exist to form …

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific …

MR Jaff, MS McMurtry, SL Archer, M Cushman… - Circulation, 2011 - Am Heart Assoc
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …

Cellular and molecular pathobiology of pulmonary arterial hypertension

M Humbert, NW Morrell, SL Archer… - Journal of the American …, 2004 - jacc.org
Pulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction,
remodeling of the pulmonary vessel wall, and thrombosis contribute to increased pulmonary …

[HTML][HTML] A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

S Bonnet, SL Archer, J Allalunis-Turner, A Haromy… - Cancer cell, 2007 - cell.com
The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance
and be therapeutically targeted. Compared to normal cells, several human cancers have …

Diversification and the reduction of dispersion: an empirical analysis

JL Evans, SH Archer - The journal of finance, 1968 - JSTOR
Sharpe suggests, that the total variation of a portfolio return may be segregated into two
forms: 2 (1) Systematic variation, resulting for covariation of the returns on the individual …

Measurement of nitric oxide in biological models

S Archer - The FASEB journal, 1993 - Wiley Online Library
Nitric oxide (NO) is a small, gaseous, paramagnetic radical with a high affinity for interaction
with ferrous hemoproteins such as soluble guanylate cyclase and hemoglobin. Interest in …

Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

SL Archer, JM Huang, V Hampl… - Proceedings of the …, 1994 - National Acad Sciences
Nitric oxide (NO)-induced relaxation is associated with increased levels of cGMP in vascular
smooth muscle cells. However, the mechanism by which cGMP causes relaxation is …

Mitochondrial dynamics—mitochondrial fission and fusion in human diseases

SL Archer - New England Journal of Medicine, 2013 - Mass Medical Soc
Mitochondria fuse and divide in response to cell demands and environment. Alterations in
mitochondrial dynamics underlie various human diseases, including cancer and neurologic …

Cellular and molecular basis of pulmonary arterial hypertension

NW Morrell, S Adnot, SL Archer, J Dupuis… - Journal of the American …, 2009 - jacc.org
Pulmonary arterial hypertension (PAH) is caused by functional and structural changes in the
pulmonary vasculature, leading to increased pulmonary vascular resistance. The process of …

Overview of the MOSAiC expedition: Atmosphere

…, A Sommerfeld, G Spreen, M Stephens… - Elem Sci …, 2022 - online.ucpress.edu
With the Arctic rapidly changing, the needs to observe, understand, and model the changes
are essential. To support these needs, an annual cycle of observations of atmospheric …